Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy

U Matulonis; P Harter; Charles Gourley; M Friedlander; I Vergote; G Rustin; C Scott; W Meier; R Shapria-Frommer; T Safra; D Matei; A Fielding; S Spencer; D Parry; L Grinsted; JA Ledermann

doi:10.1002/cncr.29995

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy

U Matulonis, P Harter, Charles Gourley, M Friedlander, I Vergote, G Rustin, C Scott, W Meier, R Shapria-Frommer, T Safra, D Matei, A Fielding, S Spencer, D Parry, L Grinsted, JA Ledermann

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Cancer
DOIs	https://doi.org/10.1002/cncr.29995
Publication status	Published - 8 Apr 2016

Access to Document

10.1002/cncr.29995

CLEAN REVISION Olaparib post progression OS manuscript rev 1 13 16
This is the authors final peer-reviewed manuscript as accepted for publication.
Accepted author manuscript, 19.6 MB

Cite this

Matulonis, U., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapria-Frommer, R., Safra, T., Matei, D., Fielding, A., Spencer, S., Parry, D., Grinsted, L., & Ledermann, JA. (2016). Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy. Cancer. https://doi.org/10.1002/cncr.29995

@article{86e58b9886d14e689a6020ccd5e925a1,

title = "Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy",

author = "U Matulonis and P Harter and Charles Gourley and M Friedlander and I Vergote and G Rustin and C Scott and W Meier and R Shapria-Frommer and T Safra and D Matei and A Fielding and S Spencer and D Parry and L Grinsted and JA Ledermann",

year = "2016",

month = apr,

day = "8",

doi = "10.1002/cncr.29995",

language = "English",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

}

Matulonis, U, Harter, P, Gourley, C, Friedlander, M, Vergote, I, Rustin, G, Scott, C, Meier, W, Shapria-Frommer, R, Safra, T, Matei, D, Fielding, A, Spencer, S, Parry, D, Grinsted, L & Ledermann, JA 2016, 'Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy', Cancer. https://doi.org/10.1002/cncr.29995

TY - JOUR

T1 - Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy

AU - Matulonis, U

AU - Harter, P

AU - Gourley, Charles

AU - Friedlander, M

AU - Vergote, I

AU - Rustin, G

AU - Scott, C

AU - Meier, W

AU - Shapria-Frommer, R

AU - Safra, T

AU - Matei, D

AU - Fielding, A

AU - Spencer, S

AU - Parry, D

AU - Grinsted, L

AU - Ledermann, JA

PY - 2016/4/8

Y1 - 2016/4/8

U2 - 10.1002/cncr.29995

DO - 10.1002/cncr.29995

M3 - Article

JO - Cancer

JF - Cancer

SN - 0008-543X

ER -